Sarah L. Sammons, Jose Pablo Leone, Thibaut Sanglier, Jocelyn Sun, Peter Lambert, Raf Poppe, Estefania Monturus, Adam Knott, Eleonora Restuccia, Nancy U. Lin, Sara M. Tolaney. "Incidence and predictors of exceptional response (ExRes) in patients (pts) initiating first-line (1L) treatment for HER2-positive (HER2+) metastatic breast cancer (MBC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e13021